Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Subtypes and Treatment Strategies of Patients with Unresectable Mixed Hepatocellular Cholangiocarcinoma Based on Multimodal Data

NCT06849180 is registered in ClinicalTrials.gov with Zhongda Hospital as lead sponsor.

NCT NCT06849180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06849180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Subtypes and Treatment Strategies of Patients with Unresectable Mixed Hepatocellular Cholangiocarcinoma Based on Multimodal Data
Lead sponsor
Zhongda Hospital
Phase
Observational
Overall status
Recruiting
Start date
December 31, 2024
Completion date
February 28, 2026
Enrollment
198 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

combined hepatocellular and cholangiocarcinoma, combined hepatocellular carcinoma and cholangiocarcinoma, combined hepatocellular-cholangiocarcinoma